Unveiling the Future of Oncology and Precision Medicine through Data Science

Apostolos Zaravinos^{1

2}

Affiliations

¹ Department of Life Sciences, School of Sciences, European University Cyprus, 2404 Nicosia, Cyprus.
² Cancer Genetics, Genomics and Systems Biology Laboratory, Basic and Translational Cancer Research Center (BTCRC), 1516 Nicosia, Cyprus.

Editorial

Apostolos Zaravinos. Int J Mol Sci. 2024.

. 2024 May 26;25(11):5797.

doi: 10.3390/ijms25115797.

Apostolos Zaravinos^{1

2}

¹ Department of Life Sciences, School of Sciences, European University Cyprus, 2404 Nicosia, Cyprus.
² Cancer Genetics, Genomics and Systems Biology Laboratory, Basic and Translational Cancer Research Center (BTCRC), 1516 Nicosia, Cyprus.

Abstract

Information generated via next-generation sequencing (NGS) technologies is often termed multi-omics data [...].

The author declares no conflicts of interest.

1. Berger M.F., Mardis E.R. The Emerging Clinical Relevance of Genomics in Cancer Medicine. Nat. Rev. Clin. Oncol. 2018;15:353–365. doi: 10.1038/s41571-018-0002-6. - DOI - PMC - PubMed
1. Mendelsohn J. Personalizing Oncology: Perspectives and Prospects. J. Clin. Oncol. 2013;31:1904–1911. doi: 10.1200/JCO.2012.45.3605. - DOI - PubMed
1. Ginsburg G.S., Phillips K.A. Precision Medicine: From Science To Value. Health Aff. Proj. Hope. 2018;37:694–701. doi: 10.1377/hlthaff.2017.1624. - DOI - PMC - PubMed
1. Tewari K.S., Sill M.W., Long H.J., Penson R.T., Huang H., Ramondetta L.M., Landrum L.M., Oaknin A., Reid T.J., Leitao M.M., et al. Improved Survival with Bevacizumab in Advanced Cervical Cancer. N. Engl. J. Med. 2014;370:734–743. doi: 10.1056/NEJMoa1309748. - DOI - PMC - PubMed
1. Colombo N., Dubot C., Lorusso D., Caceres M.V., Hasegawa K., Shapira-Frommer R., Tewari K.S., Salman P., Hoyos Usta E., Yañez E., et al. Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer. N. Engl. J. Med. 2021;385:1856–1867. doi: 10.1056/NEJMoa2112435. - DOI - PubMed